20102017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luisa Angela Gioeni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

    Aglietta, M., Barone, C., Sawyer, M. B., Moore, M. J., Miller, W. H., Bagalà, C., Colombi, F., Cagnazzo, C., Gioeni, L., Wang, E., Huang, B., Fly, K. D. & Leone, F., 2014, In : Annals of Oncology. 25, 9, p. 1750-1755 6 p., mdu205.

    Research output: Contribution to journalArticle

  • Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases: The MetaPan study

    Leone, F., Artale, S., Marino, D., Cagnazzo, C., Cascinu, S., Pinto, C., Fornarini, G., Tampellini, M., Di Fabio, F., Sartore-Bianchi, A., De Carlis, L., Pugliese, R., Capussotti, L., Gioeni, L., Siena, S. & Aglietta, M., Oct 1 2013, In : Cancer. 119, 19, p. 3429-3435 7 p.

    Research output: Contribution to journalArticle

  • Role of trastuzumab in the management of HER2-positive metastatic breast cancer

    Milani, A., Montemurro, F., Gioeni, L., Aglietta, M. & Valabrega, G., Nov 23 2010, In : Breast Cancer: Targets and Therapy. 2, p. 93-109 17 p.

    Research output: Contribution to journalArticle